RxDoctor Payments Data

Suzanne Fanelli

Physician Assistant · Massapequa, NYNPI 1588712699

Payments from drug & device makers

$3,253in general payments, 2019–2025

Across 139 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$553
  • Novartis$471
  • Johnson & Johnson$469
  • AstraZeneca$415
  • Amgen$334
  • Boston Scientific$157
  • plus $855 from 18 others

What the payments were for

  • Food & beverage$3,253100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,253 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban126$154,507
EntrestoSacubitril/Valsartan70$116,368
Repatha SureclickEvolocumab109$104,617
XareltoRivaroxaban80$95,957
JardianceEmpagliflozin24$37,876
Nurtec OdtRimegepant Sulfate11$22,096
FarxigaDapagliflozin Propanediol23$19,924
OzempicSemaglutide17$16,264
VerquvoVericiguat13$14,348
VascepaIcosapent Ethyl19$6,247
Olmesartan Medoxomil146$5,144
Rosuvastatin Calcium253$4,521
Atorvastatin Calcium376$4,011
Metoprolol Succinate245$3,826
Ezetimibe139$3,695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$60$176,603137 claims
NovartisEntresto$471$116,36870 claims
Johnson & JohnsonXarelto$469$95,95780 claims
Boehringer IngelheimJardiance$95$37,87624 claims
AstraZenecaFarxiga$415$19,92423 claims
Novo NordiskOzempic$124$16,26417 claims
MerckVerquvo$553$14,34813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Massapequa

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →